alpha-tocopherol phosphate has been researched along with ascorbate-2-phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Kanazawa, H; Mori, T; Sawaguchi, T | 1 |
| Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T | 1 |
2 other study(ies) available for alpha-tocopherol phosphate and ascorbate-2-phosphate
| Article | Year |
|---|---|
Differential effects of the ascorbyl and tocopheryl derivative on the methamphetamine-induced toxic behavior and toxicity.
Topics: alpha-Tocopherol; Animals; Antioxidants; Ascorbic Acid; Central Nervous System Stimulants; Dopamine; Electron Spin Resonance Spectroscopy; Free Radicals; Iron-Binding Proteins; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Molecular Structure; Morphine; Neurotoxicity Syndromes; Self-Injurious Behavior | 2007 |
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides | 2007 |